Skip to main content
JDRS · Open access journal

Original Article · Open access

The effects of gabapentin and pregabalin on fracture healing: A histological, radiological, and biomechanical analysis

PDF Cite this article

Ahmet Emrah Açan

Department of Orthopedics and Traumatology, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0000-0001-7116-8773

Mert Emre Aydın

Department of Orthopedics and Traumatology, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0009-0006-6124-7842

Özgür Bulmuş

Department of Physiology, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0000-0001-7736-402X

Emrah Özcan

Department of Anatomy, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0000-0002-6373-4744

Aslı Karakılıç

Department of Physiology, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0000-0001-7788-4949

Gülay Turan

Department of Pathology, Balıkesir University Faculty of Medicine, Balıkesir, Türkiye

ORCID: 0000-0002-3702-8811

Reşit Buğra Hüsemoğlu

Department of Biomechanics, Dokuz Eylül University Institute of Health Sciences, İzmir, Türkiye

ORCID: 0000-0003-1979-160X

Abstract

Objectives: This study evaluated the impact of different doses of gabapentin and pregabalin on fracture healing in a rat femoral shaft model, with histological, radiological, and biomechanical assessments.

Materials and methods: Seventy male Wistar albino rats were divided into five groups: control, low-dose gabapentin (GBP-L, 300 mg/day), high-dose gabapentin (GBP-H, 3600 mg/day), low-dose pregabalin (PRG-L, 150 mg/day), and high-dose pregabalin (PRG-H, 600 mg/day), based on human equivalent doses. Bilateral femoral fractures were induced; the right femurs were prepared for radiological examination using microtomography, followed by histological analysis, whereas the left femurs were allocated for biomechanical testing. Drug administration began three weeks preoperatively and continued until sacrifice at either two or four weeks. Histological assessments included inflammation and transformation scoring and microtomography-measured callus volume. Biomechanical testing assessed maximum force and stiffness.

Results: At the fourth week, inflammation levels were significantly higher in the GBP-H, PRG-L, and PRG-H groups compared to control (p<0.01, p<0.05, and p<0.01), while transformation scores were significantly lower in these groups (p<0.01, p<0.05, and p<0.001). Low-dose pregabalin showed a borderline transformation difference (p=0.051). Microtomography analysis showed that the GBP-H group had significantly reduced callus volume versus control by the second week (p<0.01), persisting at a lower significance by week four (p<0.05). By the fourth week, PRG-H also had reduced callus volume (p<0.05). Maximum force values by the fourth week were significantly lower in the GBP-L, GBP-H, and PRG-H groups compared to control (p<0.05 for GBP-L; p<0.01 for GBP-H and PRG-H).

Conclusion: These findings suggest that these drugs, particularly with their high-dose applications, may lead to prolonged inflammation and hinder fracture healing by reducing callus volume and biomechanical integrity, potentially disrupting the transition from the inflammatory to reparative phases of healing.

Declarations

Author Contributions

Idea/concept, literature review, design, conducted the study and writing the article: A.E.A.; Materials and conducted the study: A.M.E.; Materials, supervision of the study and critical review of the manuscript: B.Ö.; Data collection, analysis and interpretation: Ö.E., K.A., T.G., T.N., H.R.B. All authors read and approved the final manuscript.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

This study was supported solely by our university’s scientific research fund. No author has any professional or financial relationships that could be perceived as influencing the impartiality of the presentation.

Acknowledgments

The statistics were performed by Prof. Sinan Saraçlı, Department of Biostatistics, Faculty of Medicine, Balıkesir University.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.